Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secukinumab in moderate to severe plaque psoriasis
NCT05891964Phase 4Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Jul 2021
- Primary completion
- Jun 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of secukinumab in plaque psoriasis, sponsored by Jinnah Postgraduate Medical Centre. Started Jul 2021; status: completed.
02
Drugs
secukinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05891964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05891964.